INTRODUCTION
Astrocytes tile the entire central nervous system, serve essential support functions, and contribute to disease. In addition, astrocytes regulate synapse formation, removal, and function, as well as regulate blood flow (Allen, 2014; Bazargani and Attwell, 2016) .
Astrocytes also respond with intracellular calcium elevations during distinct responses in vivo such as locomotion and startle (Shigetomi et al., 2016) , and they are implicated in the regulation of complex mouse behaviors (Halassa and Haydon, 2010) .
A key necessity to studying astrocytes in vivo is the ability to manipulate them selectively without concomitantly impacting other cells. From this perspective, much attention has focused on genetic methods to selectively target astrocytes (Davila et al., 2013; Xie et al., 2015) . Cell-type-specific expression of Cre recombinase (Cre) is frequently used to achieve gene expression and deletion by exploiting the Cre-loxP system (Sauer, 1994; Tsien, 2016) . However, existing mouse lines expressing Cre under the control of astrocyte promoters are neither selective for astrocytes nor pan-astrocytic (Khakh and Sofroniew, 2015; Xie et al., 2015; Zhang and Barres, 2010) . Furthermore, several of the commonly used mouse lines express Cre from birth, which vitiates inducible gene expression/deletion in adult mice and complicates analyses of complex behaviors and disease mechanisms. In addition, several available Cre lines are known to target neural stem cells, compromising interpretation of behavior in adults. Overall, existing astrocyte Cre lines display some, several, or all of these shortcomings, and thus fall short of minimal experimental requirements for cell specificity (Xie et al., 2015) . For example, widely used hGfap-Cre lines target large populations of neurons (Sun et al., 2016; Zhuo et al., 2001) , and several mGfap-Cre and Slc1a3-Cre/ERT lines target neural progenitors that give rise to neurons in the olfactory bulb and hippocampus (Garcia et al., 2004; Gregorian et al., 2009; Niu et al., 2013; Slezak et al., 2007) and smaller populations of neurons elsewhere (Xie et al., 2015) . This problem is shared with mice constitutively expressing Cre under the control of the Aldh1l1 promoter (Foo and Dougherty, 2013) . Hence, the field lacks a reliable method to achieve pan-astrocytic, specific, and inducible genetic manipulations in order to explore astrocyte physiology in vivo. The limitations of Gfap-based mouse lines have been discussed (Sloan and Barres, 2014; Su et al., 2004) .
The GENSAT project (Gong et al., 2003) found that the aldehyde dehydrogenase 1 family member L1 (Aldh1l1) gene marked astrocytes, a finding confirmed by subsequent RNA (Cahoy et al., 2008; Molofsky and Deneen, 2015; Zhang et al., 2014 Zhang et al., , 2016 , lineage (Molofsky et al., 2013) , and expression analyses (Cahoy et al., 2008; Foo and Dougherty, 2013) . This raised the possibility that Aldh1l1 could be used as a genetic locus to express tamoxifeninducible Cre/ERT2 and thus achieve temporally specific pan-astrocytic genetic manipulations. In the present study, we explored this possibility using BAC transgenesis (Yang and Gong, 2005) . In order to characterize the Aldh1l1-Cre/ERT2 mice, we used immunohistochemistry (IHC) and Cre-dependent FLEX-GFP adeno-associated viruses (AAVs) (Atasoy et al., 2008) . We also used genetic crosses of the Aldh1l1-Cre/ERT2 mice with Ai95 mice that express cytosolic GCaMP6f (cyto-GCaMP6f) in a Credependent manner Madisen et al., 2015) . Furthermore, in light of studies showing that membrane-targeted Lck-GCaMPs reliably report calcium signals in astrocyte processes (Haustein et al., 2014; Shigetomi et al., 2010 Shigetomi et al., , 2013 , we generated knockin mice at the ROSA26 locus for Cre-dependent Lck-GCaMP6f, crossed these to Aldh1l1-Cre/ERT2 mice, and characterized the offspring using in situ and in vivo imaging. Finally, we crossed the Aldh1l1-Cre/ERT2 mice with RiboTag mice that express the ribosomal protein Rpl22HA in a Cre-dependent manner (Sanz et al., 2009) . We used this strategy to determine the cortical astrocyte transcriptome in adult mice, which we compared to data from postnatal day 7 (P7) mice (Zhang et al., 2014) . Our studies provide well-characterized, much needed, and easy-to-use resources.
RESULTS
Generation of BAC Transgenic Aldh1l1-Cre/ERT2 Mice The Cre lines used are named according to the gene (Table 1) . Cre/ERT2 was inserted at the ALDH1L1 gene (Aldh1l1) start codon within the BAC DNA ( Figure 1A ). Insertion was confirmed by PCR using flanking and insert-specific primers and with restriction analyses. The Cre/ERT2 sequence harbors a rare AsiS1 restriction site and cutting with AsiS1 linearized the modified BAC ( Figure S1A , available online). The modified Aldh1l1-Cre/ERT2 BAC clone was used for pronuclear injections after detailed characterization with PCR over regions of Aldh1l1 and Cre/ERT2. Following injection of $200 embryos, two founder lines of transgenic mice were generated (Aldh1l1-Cre/ERT2; lines 1 and 2). Both resulted in germline transmission and were identical in initial experiments that are described below for line 1. The insertion of Cre/ERT2 was confirmed by PCR of tail biopsy genomic DNA and by characterization with PCR over regions of Aldh1l1 ( Figure S1B ). Identical methods were used to make Slc6a11-Cre/ERT2 mice at the GABA transporter type 3 (GAT3) locus. Both the Aldh1l1-and Slc6a11-Cre/ERT2 mice reproduced, provided offspring in expected numbers, and displayed no obvious behavioral alterations. This was expected because the BAC method leaves both copies of the endogenous genes intact while achieving expression from the full-length locus within the BAC (Yang and Gong, 2005) .
Testing of Aldh1l1-Cre/ERT2 Mice in Relation to Other Commonly Used Cre Lines We initially tested for Cre/ERT2-mediated expression of GFP within adult Aldh1l1-Cre/ERT2 mice using IHC 14-21 days after microinjections (i.e., at $P80) of Cre-dependent AAV FLEX-GFP, followed by tamoxifen induction (Atasoy et al., 2008) . With this strategy, GFP is expressed in cells that express Cre. As a control, we injected AAV FLEX-GFP into the hippocampus of Aldh1l1-Cre/ERT2 mice, and in the absence of tamoxifen we detected no GFP expression in astrocytes based on cell morphology or co-localization with the astrocyte marker S100b in 40 mm hippocampal sections ( Figure 1B ; n = 4 mice). However, we did detect GFP expression in a small number of neurons ($50), which represents leaky expression from the AAV FLEX-GFP (Figures 1B and 1F ; n = 4 mice). Later, we report no detectable leakiness from the Aldh1l1-Cre/ERT2 mouse line. However, with the AAV FLEX-GFP controls, we microinjected AAV FLEX-GFP into the hippocampi of mGfap-Cre 77.6 mice (Gregorian et al., 2009 ) that constitutively express Cre in GFAP-positive cells. We observed expression of GFP in 306 ± 27 astrocytes, but also in a substantial population of neurons (123 ± 12) throughout the hippocampus (arrows in Figures 1C and 1F ; n = 4 mice). We repeated these experiments with Slc1a3-Cre/ ERT mice at the GLAST glutamate transporter locus (Slezak et al., 2007) and again noted clear GFP expression in astrocytes (148 ± 21) and large numbers of neurons (207 ± 61; arrows in Figures 1D and 1F; n = 4 mice) . Similar experiments were performed for Gjb6-Cre/ERT2 (Slezak et al., 2007) and Slc6a11-Cre/ERT2 mice (Figures S1 and 1F; n = 4 mice); the numbers of labeled astrocytes and neurons were 374 ± 14 and 81 ± 14, and 104 ± 14 and 104 ± 19 for Gjb6-Cre/ERT2 and Slc6a11-Cre/ERT2 mice, respectively. Thus, in the case of mGfap-Cre, Slc1a3-Cre/ ERT, Gjb6-Cre/ERT2, and Slc6a11-Cre/ERT2, the number of GFP-expressing neurons as a percentage of GFP-expressing astrocytes in the hippocampus was 40%, 140%, 21%, and 101%, respectively (n = 4 mice of each genotype). In contrast, with Aldh1l1-Cre/ERT2 mice we detected GFP expression in large numbers of astrocytes (360 ± 73) and in essentially no neurons (36 ± 2 versus the AAV control of 50 ± 9; Figures 1E and 1F; Table 1 ; n = 4 mice). We emphasize that the comparison of different Cre lines shown in Figure 1 and Table 1 relates to the hippocampus at P80. We do not rule out judicious use of existing Cre lines or the need for further controls. The astrocytes labeled with GFP from AAV FLEX-GFP in the Aldh1l1-Cre/ERT2 mice displayed typical, unambiguous, complex bushy astrocyte morphologies and co-localized with (G-J) Representative high-magnification images of CA1 astrocytes in the Aldh1l1-Cre/ERT2 mouse showing co-staining for S100b (G), GFAP (H), and Glt1 (I), but not NeuN (J). In (B)-(G), the sections were stained for GFP (green) and S100b (red). The data are shown as mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the mean. S100b, GFAP, and Glt1, but not with NeuN (Figures 1G-1J ; n = 4 mice each; Figure S1E ). A single pan-astrocyte antibody marker does not exist, but the bushy morphologies and co-localization with S100b, GFAP, and Glt1 provides strong evidence that the GFP-expressing cells were astrocytes.
Generation of Lck-GCaMP6f
flox Mice at the ROSA26
Locus
Genetically encoded calcium indicators (GECIs) can be expressed in specific cells and offer advantages over organic calcium indicators for studying astrocyte calcium signaling. GCaMP6f has fast kinetics and higher signal to noise than its predecessors , and Cre-dependent knockin mice at the ROSA26 locus are available (Madisen et al., 2015) . Plasma membrane targeting of GCaMP6f improves its ability to reveal calcium signals in nearmembrane regions and fine processes of astrocytes (Shigetomi et al., 2016) . In light of this, we made knockin Lck-GCaMP6f mice at the ROSA26 locus (Lck-GCaMP6f flox ) in which GCaMP6f is targeted to the plasma membrane by an Lck tag and expressed in a Cre-dependent manner (Figures 2A-2C) .
We initially tested Lck-GCaMP6f flox mice by injecting AAV2/5
GfaABC 1 D Cre into the hippocampus of adult mice. We also used the same AAV to express cyto-GCaMP6f in Ai95 mice. In both cases, we noted expression of Lck-GCaMP6f and cytoGCaMP6f in S100b-positive astrocytes and neurons in the hippocampus (Figures S2A-S2F Figure S3H ). These initial experiments demonstrate the potential utility of Lck-GCaMP6f-flox mice in relation to Ai95 mice.
Validating Aldh1l1-Cre/ERT2 Mice by Crosses with Lck-GCaMP6f flox and Ai95 Mice We crossed both Ai95 and Lck-GCaMP6f flox mice with Slc1a3-Cre/ERT and Aldh1l1-Cre/ERT2 mice. We induced gene expression with tamoxifen (75 mg/kg once per day for 5 days at $P56) in the offspring that were heterozygous for both alleles and studied GCaMP6f expression 2-3 weeks later with IHC (i.e., at $P80; Figure 2 ). We did not examine reporter expression in neonatal mice or in adult mice greater than 3 weeks after tamoxifen.
Cyto-GCaMP6f and Lck-GCaMP6f expression was sparse with Slc1a3-Cre/ERT mice, but expression of both GECIs was ubiquitous and high with Aldh1l1-Cre/ERT2 mice (Figures 2D-2G; n = 4 mice each). Indeed, the entire brain was green when either Lck-GCaMP6f or cyto-GCaMP6f was driven with the Aldh1l1-Cre/ERT2 mouse line ( Figures 2F-2M ). Occasional astrocytes that did not express GCaMP6f appeared as dark patches in an otherwise uniformly green neuropil (white arrows; Figure 2F ). This was clear from higher magnification images; the dark patches contained S100b-positive astrocytes (Figures 2H and 2I) . It was clear that Lck-GCaMP6f and cyto-GCaMP6f were expressed in the vast majority of S100b-positive astrocytes in the hippocampus, visual cortex, and striatum, with occasional patches of S100b-positive cells that lacked the GECIs ( Figures  2H-2M ). Furthermore, examination of example brain areas in sagittal sections showed that Aldh1l1-Cre/ERT2 resulted in astrocyte GCaMP6f expression throughout the brain (Movie S1).
Overall, Aldh1l1-Cre/ERT2 mice resulted in GECI expression in >90% of astrocytes in the hippocampal CA1, CA3, and dentate gyrus (DG) regions; in V1 of the visual cortex; and in the striatum (Figures 3A and 3B; n = 4 mice for each case). In contrast, Slc1a3-Cre/ERT resulted in expression of Lck-GCaMP6f or cyto-GCaMP6f in $20%-40% of astrocytes in the same areas (Figures 3A and 3B; n = 4 mice each).
As expected (Slezak et al., 2007) , Slc1a3-Cre/ERT resulted in GECI expression in granule cells of the DG (yellow arrows; Figures 2D and 2E ; n = 4 mice), but expression in the mossy fiber pathway was only observed for Lck-GCaMP6f (pink arrow; Figure 2D) , which implies that Lck-GCaMP6f traffics more efficiently than cyto-GCaMP6f to axons and nerve terminals. No similar neuronal expression was observed with Aldh1l1-Cre/ERT2 mice (n = 4 mice; Figures 2F and 2G). We also performed a specific set of experiments to evaluate GCaMP6f expression in stained for Lck-GCaMP6f (green) and S100b (red); the pyramidal cell layer (Pyr) and stratum radiatum (S.r) are indicated. The white arrow shows an astrocyte with S100b that lacks Lck-GCaMP6f expression. The panels to the right separately show Lck-GCaMP6f staining using a GFP antibody and S100b staining.
(I) Representative image of the hippocampal CA1 region from an Ai95 3 Aldh1l1-Cre/ERT2 double transgenic mouse injected with tamoxifen and stained for cytoGCaMP6f (green) and S100b (red). The white arrow shows an astrocyte with S100b lacking cyto-GCaMP6f expression. The panels to the right separately show cyto-GCaMP6f staining using a GFP antibody and S100b staining. (J and K) As in (H) and (I), but for V1 of the visual cortex. (L and M) As in (H) and (I), but for the striatum.
neurogenic zones of the brain by examining co-localization with NeuN, which is one of several markers that label newly born neurons (Garcia et al., 2004) . Thus, we found no significant co-localization between NeuN and GCaMP6f driven by Aldh1l1-Cre/ ERT2 in the subgranular zone (SGZ), DG, subventricular zone (SVZ), rostral migratory stream (RMS), or the granule cell layer of the olfactory bulb (GCL OB; Figure S4 ; n = 4 mice each). The data illustrate the pan-astrocyte and specific nature of Cre-dependent gene expression driven by Aldh1l1-Cre/ERT2 in adult mice at $P56 when evaluated $3 weeks after the final tamoxifen injection with a standard 5-day induction protocol. We acquired higher magnification images of Lck-and cytoGCaMP6f-expressing astrocytes from the CA1 region of the hippocampus, V1 area of the visual cortex, and striatum when Cre was expressed either from the Slc1a3-Cre/ERT or the Aldh1l1-Cre/ERT2 mouse lines ( Figures 3C-3N ). In all three areas, we noted that Lck-GCaMP6f was expressed within entire bushy astrocytes ( Figures 3C-3N ). Because expression driven by Aldh1l1-Cre/ERT2 occurred in virtually all astrocytes, individual astrocyte territories were hard to delineate ( Figures 3C, 3D , 3G, 3H, 3K, and 3L). In contrast, individual astrocyte territories could be easily delineated in mice in which expression was driven by Slc1a3-Cre/ERT mice ( Figures 3E, 3F , 3I, 3J, 3M, and 3N). Moreover, by comparing the expression of LckGCaMP6f to that of cyto-GCaMP6f, irrespective of the Cre/ ERT line used or the brain area, it was apparent that the membrane-tethered Lck-GCaMP6f labeled the surface area of astrocytes whereas cyto-GCaMP6f mostly revealed internal volumes (Figure 3) . Thus, there were Cre-line-independent, precise differences in the subcellular pattern of GECI expression in astrocytes as revealed by Lck-GCaMP6f and cyto-GCaMP6f (Figures 3C, 3D , 3G, 3H, 3M, and 3N). This speaks to the utility of both knockin mouse lines expressing Lck-GCaMP6f and cytoGCaMP6f to comprehensively study astrocyte calcium signals.
No Detectable Leaky Reporter Expression with
Aldh1l1-Cre/ERT2 Mice We examined the possibility of leaky GCaMP6f reporter expression in the absence of tamoxifen in Aldh1l1-Cre/ERT2 mice. The injection of corn oil instead of tamoxifen resulted in no detectable GCaMP6f expression, whereas in parallel controls, injection of tamoxifen clearly did ( Figure S5 ; n = 4 mice each). As reported in earlier sections, in these additional controls, we did not find any evidence for GCaMP6f co-localization with NeuN when tamoxifen was administered ( Figure S5 ). In the absence of tamoxifen, there was no detectable GCaMP6f expression (Figure S5 ; n = 4 mice). As far as we can ascertain, there was no leakiness in the Aldh1l1-Cre/ERT2 mouse line. As expected, the level of GCaMP6f expression in the hippocampus, V1 visual cortex, or striatum was dependent on the tamoxifen dose (25-225 mg/kg; Figure S6 ; n = 3 mice).
In Situ Calcium Imaging: Aldh1l1-Cre/ERT2 Mice 3 LckGCaMP6f flox or Ai95 Mice We next determined whether Aldh1l1-Cre/ERT2 mice would drive GECI expression sufficient for astrocyte calcium imaging. We studied astrocyte calcium signals in acute brain slices of V1 visual cortex following tamoxifen induction in adult mice ( Figure 4A ). Astrocytes respond to endogenously released noradrenaline with calcium elevations mediated by a1 adrenoceptors (Ding et al., 2013) . We probed this process in situ with Lck-GCaMP6f and cyto-GCaMP6f mice by applying 10 mM phenylephrine, an a1 adrenoceptor agonist, in the continued presence of tetrodotoxin (TTX) (0.5 mM) to minimize secondary effects of neuronal activation. In astrocytes expressing LckGCaMP6f or cyto-GCaMP6f, phenylephrine (PE) evoked robust calcium elevations (Figures 4B-4E ; n = 17-18 cells, 5 mice each). In addition, large amplitude spontaneous calcium signals could be detected with both GECIs (Figures 4D and 4E ) driven by Aldh1l1-Cre/ERT2.
The PE-evoked calcium signals in cortical astrocytes were significantly smaller when detected with Lck-GCaMP6f as compared to cyto-GCaMP6f for both somata and processes (Figures 4D-4G ; n = 14, 12 cells, n = 5 mice). However, they were also significantly faster in somata and processes, a finding that was clear from the raw traces and average data ( Figures 4D-4G ). We interpret this to support the view that PE-evoked calcium signals are largely driven by intracellular release and hence are optimally detected in terms of amplitude and duration by cyto-GCaMP6f, rather than by Lck-GCaMP6f, which may detect (H) Representative staining for cyto-GCaMP6f (green) and S100b (red) in the V1 visual cortex of Ai95 3 Aldh1l1-Cre/ERT2 double transgenic mice. (I) Representative staining for Lck-GCaMP6f (green) and S100b (red) in the V1 visual cortex of Lck-GCaMP6f flox 3 Slc1a3-Cre/ERT double transgenic mice.
(J) Representative staining for cyto-GCaMP6f (green) and S100b (red) in the V1 visual cortex of Ai95 3 Slc1a3-Cre/ERT double transgenic mice. (K) Representative staining for Lck-GCaMP6f (green) and S100b (red) in the striatum of Lck-GCaMP6f flox 3 Aldh1l1-Cre/ERT2 double transgenic mice.
(L) Representative staining for cyto-GCaMP6f (green) and S100b (red) in the striatum of Ai95 3 Aldh1l1-Cre/ERT2 double transgenic mice. (M) Representative staining for Lck-GCaMP6f (green) and S100b (red) in the striatum of Lck-GCaMP6f flox 3 Slc1a3-Cre/ERT double transgenic mice.
(N) Representative staining for cyto-GCaMP6f (green) and S100b (red) in the striatum of Ai95 3 Slc1a3-Cre/ERT double transgenic mice. The data are shown as mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the mean.
the PE-evoked signals only as they spread to the plasma membrane. Spontaneous signals were also readily detected by Aldh1l1-Cre/ERT2-mediated GECI expression, and their properties are reported in detail in Figure 4H . The most notable difference between cyto-GCaMP6f and Lck-GCaMP6f was that $33% more ROIs were detected per cell with Lck-GCaMP6f than with cyto- GCaMP6f and that the calcium signals in these ROIs covered significantly smaller areas at 26 ± 3 and 59 ± 5 mm 2 for LckGCaMP6f and cyto-GCaMP6f, respectively ( Figure 4H ; n = 17 and 18 cells, n = 5 mice each). Application of Ca 2+ free buffers significantly reduced the frequency of Ca 2+ signals measured with Lck-GCaMP6f in somata and processes, but had no effect on Ca 2+ signals measured with cytoGCaMP6f ( Figure 4I ; n = 13 cells and 4 mice). These observations are consistent with studies suggesting that plasma membrane-targeted GECIs identify transmembrane calcium microdomains within astrocytes (Jackson and Robinson, 2015; Melom and Littleton, 2013; Shigetomi et al., 2010 Shigetomi et al., , 2013 . Overall, Aldh1l1-Cre/ERT2-mediated expression of Lck-GCaMP6f reveals aspects of astrocyte calcium signaling separable and distinct from that reported with cyto-GCaMP6f.
Cortical Astrocyte Ca 2+ Signals In Vivo Measured with
GECIs Driven by Aldh1l1-Cre/ERT2 Astrocytes in the visual cortex respond with robust calcium elevations during arousal/startle due to the release of noradrenaline from noradrenergic projections via a mechanism likely involving a1 adrenoceptors on astrocytes (Shigetomi et al., 2016) . We next In brief, after the mice were injected with tamoxifen for 7 days, a lightweight metal head bar was glued to their skull and a 3 mm cranial window was made above the visual cortex. Mice were then head-fixed onto a spherical treadmill where they were free to rest or run. A 403 objective lens as part of a twophoton laser scanning imaging microscope was positioned above the cranial window. An air pump outside the microscope enclosure was used to generate an unexpected air puff, which evoked startle response. The data are shown as mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the mean.
tested if astrocyte GECI expression driven by Aldh1l1-Cre/ERT2 mice could detect calcium signals in vivo from non-anesthetized awake behaving mice. We measured spontaneous calcium signals and those triggered by startle, which was elicited by a gentle puff of air to the face ( Figure 5A ). The representative images and traces shown in Figures 5B and 5C and the average traces in Figures 5D and 5E demonstrate that Aldh1l1-Cre/ERT2 drove GECI expression in cortical astrocytes sufficiently to detect spontaneous and startle-evoked astrocyte calcium signals. Past work shows that cortical astrocytes display calcium elevations during voluntary locomotion (Paukert et al., 2014 ), which we tracked by recording the movement of the spherical treadmill on which the mice stood ( Figure 5A ). We next separated astrocyte calcium signals into those that were triggered by startle, those that occurred during voluntary locomotion, and those that occurred independently of locomotion and startle, i.e., when the mouse was resting (Figures 5F-5H ). The main difference between Lck-GCaMP6f and cyto-GCaMP6f with respect to the startle-evoked calcium signals was in the areas that the calcium signals encompassed: the areas were significantly smaller for Lck-GCaMP6f ( Figure 5F ; 118 and 96 ROIs, n = 4 mice each). This was also observed for the calcium signals that occurred during voluntary locomotion ( Figure 5G) . Otherwise, the startle-evoked and locomotion-associated astrocyte calcium signals were similar in terms of amplitude and halfwidth ( Figures 5F and 5G ).
In the case of calcium signals that occurred during resting, we found that Lck-GCaMP6f revealed significantly more signals than cyto-GCaMP6f by a factor of $60. Thus, the frequency (number of events in 100 s) was 23 ± 8 and 0.4 ± 0.3 for Lck-GCaMP6f and cyto-GCaMP6f, respectively ( Figure 5H ; p = 0.008). Moreover, the areas of these events were also significantly smaller in the case of Lck-GCaMP6f than those detected by cyto-GCaMP6f ( Figure 5H ; p < 0.0001). They tended to be larger in amplitude, but this did not reach statistical significance, likely because few similar events existed in the cyto-GCaMP6f group ( Figure 5H) . Overall, these data show that Aldh1l1-Cre/ ERT2 mice can drive Lck-GCaMP6f and cyto-GCaMP6f to permit measurement of calcium signals in awake behaving mice ( Figure 5) .
The signals measured in vivo with Lck-GCaMP6f were generally smaller in area and more microdomain-like, which recalls Figure 4 . These data also emphasize that studying astrocytes (B) As in (A), but for in vivo startle-evoked response in the visual cortex. In both cases, many more astrocytes were detected when cyto-GCaMP6f was driven by the Aldh1l1-Cre/ERT2 mouse. The data are shown as mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the mean.
in vivo with cytosolic and membrane-targeted GECIs reveals distinct aspects of calcium signaling. This is relevant given that astrocyte calcium signals are recognized to be heterogeneous and to include significant transmembrane contributions (Jackson and Robinson, 2015; Khakh and Sofroniew, 2015; Melom and Littleton, 2013; Srinivasan et al., 2015) . The P7 cortical astrocyte transcriptome (Zhang et al., 2014 ) also shows the presence of several channel and pump mRNAs that may underlie astrocyte calcium signals; we provide appropriate genetic tools to study these systematically.
Aldh1l1-Cre/ERT2 Mice Permit High-Density Calcium Imaging of Astrocytes IHC evaluations (Figures 1, 2, and 3) showed that Aldh1l1-Cre/ ERT2 targets most astrocytes. We next determined if this was also the case for live-cell imaging in brain slices and in vivo. We repeated the key experiments shown in Figures 4 and 5 with mice in which cyto-GCaMP6f was driven by Slc1a3-Cre/ ERT (n = 4 mice) and compared these data to those where cyto-GCaMP6f was driven by Aldh1l1-Cre/ERT2 (n = 4 mice). We found that many more astrocytes could be imaged with Aldh1l1-Cre/ERT2-driven GCaMP6f expression both for acute brain slices and in vivo during startle responses (Figure 6 ). These differences were highly significant for brain slices ( Figure 6A ; p < 0.0001) and for in vivo startle-evoked responses ( Figure 6B ; p = 0.003). The data demonstrate that the use of Aldh1l1-Cre/ ERT2 mice permits high-density imaging of astrocyte calcium signaling.
Aldh1l1-Cre/ERT2 3 Ribotag Mice Reveal the Adult Cortical Astrocyte Transcriptome In order to determine the cortical astrocyte transcriptome from adult mice, we crossed Aldh1l1-Cre/ERT2 mice with RiboTag mice that express the ribosomal protein Rpl22HA in a Cre-dependent manner (Sanz et al., 2009 ). We found Rpl22HA was strongly expressed in S100b-positive cortical astrocytes, but not in NeuN-positive neurons (Figures 7A and 7B ; n = 4 mice). We used standard methods ( Figures 7C and 7D) to The representative western blot shows that Rpl22HA was preserved in the IP sample, whereas b-actin was depleted in relation to input. In contrast, there was no Rpl22HA in the supernatant. In the IP lane, the 25 and 50 kD bands are the light and heavy chains of the anti-HA antibody that was used in the IP.
(legend continued on next page) immunoprecipitate (IP) Rpl22HA-containing ribosomes and their associated actively translated mRNAs (Sanz et al., 2009) , and performed RNA sequencing (RNA-seq) to determine the transcriptome of cortical astrocytes at P80 (in quadruplicate). Table  S4A contains the results of the entire P80 RNA-seq for the astrocyte IP fraction as well as the input ''soup'' from all cortical cells ( Figure 7C) . We found the P80 astrocyte transcriptome (Figure 7E) replete with several known astrocyte markers (Zhang et al., 2014) , but depleted of markers for neurons, oligodendrocytes, and microglia ( Figures 7E and S7) . Figure S7 plots the row Z score values from our P80 dataset for the top 50 genes that were astrocyte enriched in P7 cortical astrocytes (Zhang et al., 2014) . Most of these are also enriched in the P80 dataset, but there were exceptions indicating abundant astrocyte-enriched P7 genes that were differentially expressed at P80 ( Figure S7 ). In order to compare P7 and P80 across the whole dataset, we determined the 4,727 transcripts enriched in astrocytes in either dataset and used the rank-rank hypergeometric overlap (RRHO) method (Plaisier et al., 2010; Stein et al., 2014) to compare their relative rank according to FPKM (fragments per kilobase of transcript per million mapped reads) percentile ( Figure 7F ). Most transcripts were significantly clustered along the diagonal, which indicates similarity in rank between P7 and P80 ( Figure 7F ). However, many transcripts did not cluster near the diagonal, indicating different expression between P7 and P80; these can be seen more clearly in the scatter graph in Figure 7F . Figure 7G plots heatmaps for the top 34 differentially expressed genes between P7 and P80 (i.e., delta percentile > 0.1), and Table S1 reports the results of gene ontology (GO) analyses for these 34, listed in Table S2 .
Examination of Figure 7G also reveals several genes that are markedly altered between P7 and P80: the genes encoding membrane proteins (Slc1a3) GLAST, (Slc1a2) Glt1, (Slc6a11) GAT3, (Slc6a1) GAT1, and (Gja1) Cx43, and the genes for a calcium-binding protein and a chondroitin sulfate proteoglycan (Sparcl1 and Bcan). Similar changes are summarized in Table  S3 for several genes that are frequently invoked in astrocyte biology. Glul was highly expressed, but increased substantially at P80 (Table S3) . Moreover, as expected , mGluR2 receptor (Grm2) expression was increased in the P80 dataset relative to P7, and mGluR5 (Grm5) was decreased at P80 relative to P7 (Table S3 ). As expected, Grm2 was not astrocyte enriched at P7 or P80 (N/E in Table S3 ). Of the known astrocyte secreted factors, HEVIN (Sparcl1) was higher at P80 and thrombospondins 1-3 were lower at P80 relative to P7. Vesicular neurotransmitter transporters for glutamate, acetylcholine (ACh), nucleotides, GABA, and monoamines were all very low in astrocytes at both P7 and P80, although vGlut1 (Slc17a7) was higher at P80 than at P7 (Table S3) . None of these transporters were astrocyte enriched (Table S3 ). The role of astrocyte vesicular gliotransmission remains debated, and our P80 dataset, along with Aldh1l1-Cre/ERT2 mice, will be useful to plan specific experiments in adult mice. Broadly, however, our data are in accord with those at P7 (Zhang et al., 2014) and show low mRNA for known vesicular neurotransmitter transporters (Table  S3 ). This brief analysis illustrates that astrocyte P80 RNA-seq data provide validation of the Aldh1l1-Cre/ERT2 mouse and a resource to explore the functions of specific genes enriched in adult astrocytes (Figure 7 ) as well as those that are not enriched, but change in relative expression between P7 and P80 astrocytes (Table S4C ).
DISCUSSION
We have developed much needed transgenic mouse resources that will advance our ability to explore astrocyte biology within neural circuits in brain slices and, most importantly, in vivo.
First, extending pioneering transcriptome studies (Cahoy et al., 2008) , we provide well-characterized Aldh1l1-Cre/ERT2 mice that allow for specific, regulated, and pan-astrocytic gene expression under the conditions we report (induction at $P56 and assessment at $P80). These mice will be invaluable to studying astrocyte biology at different developmental stages, during disease processes, and in the context of injury and trauma. However, we believe the use of these mice will be particularly important to tease apart, through loss-and gain-of-function studies, the roles that astrocytes play at synapses, in neural circuits, and in their contributions to mouse behavior (Allen, 2014) . This has been a challenging problem to attack, especially with regard to gliotransmision (Sloan and Barres, 2014) . In addition, several brain diseases are now considered to be non-cell autonomous and to include important astrocyte contributions (Barres, 2008) . Aldh1l1-Cre/ERT2 mice will allow researchers to directly express and delete the disease-causing genes specifically in astrocytes in a temporally controlled manner and thus tease apart disease mechanisms that may yield new therapeutic targets. This has been a critical issue that existing astrocyte-specific genetic strategies have not conclusively addressed. With appropriate controls for age, disease settings, and brain area in each case, we expect Aldhll1-Cre/ERT2 mice to fill this void.
Second, we provide knockin Lck-GCaMP6f flox mice at the ROSA26 locus. These mice will be necessary to directly measure (G) A heatmap showing relative expression (row Z score) of the 32 genes whose percentile FPKM differs by at least 0.1 between highly expressed P80 and P7 cortical astrocytes determined by RRHO algorithm. These genes and their FPKM values are reported in Table S2 .
All genes for the analysis in (F) and all the raw data are provided as part of Table S4 . The data used for P7 were from Zhang et al. (2014) . The data are shown as mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the mean.
calcium signals in astrocyte processes. The use of these mice, along with Ai95 mice, will help us to understand the molecular basis of the diverse calcium signals that astrocytes display and permit exploration of the rules for neuron-to-astrocyte calcium signaling (Shigetomi et al., 2016) . Of note, the Lck-GCaMP6f flox mice represent robust tools to explore calcium signals in astrocyte processes, i.e., in locations where most physiological signaling may occur. The general nature of the Lck-GCaMP6f flox mice also means that the GECI could be expressed in any cell type for which a Cre line is available; they may be useful to study calcium signals in axons, nerve terminals, and dendritic spines. Third, we provide initial assessment of astrocyte calcium signals in V1 cortical slices and in vivo in awake head-fixed mice using both Lck-GCaMP6f and cyto-GCaMP6f during startle, spontaneous locomotion, and resting states. These data illustrate the similarities and key differences between measuring calcium signals in the cytosol and in near-membrane regions and provide a rationale for future studies in vivo. The high-density imaging enabled by the use of Aldh1l1-Cre/ERT2 mice opens up the possibility of imaging astrocyte calcium signals in freely behaving mice equipped with miniature wearable microscopes and perhaps even transcranially.
Fourth, we provide an RNA-seq dataset for astrocyte-enriched genes at P80, which can be used in conjunction with a previously reported dataset for P7 to focus on individual genes and molecular pathways at these two ages. The combination of these two datasets will permit precise exploration of astrocyte signaling in vivo and allow for exploration of mechanisms based on knowledge of adult gene expression patterns in the cortex. Initial analyses already suggest several new mechanisms to explore (see Figure 7) . The adult mouse cortical dataset is also valuable to compare with human mature astrocyte transcriptome datasets that have recently become available (Zhang et al., 2016) . The Aldh1l1-Cre/ERT2 3 RiboTag mice are the tools of choice to document astrocyte similarities and differences between distinct areas of the brain. Thus, our RNA-seq data provide a basis to explore astrocyte diversity between specific adult neural circuits and brain areas (Khakh and Sofroniew, 2015; Zhang and Barres, 2010) .
As exploration of astrocytes in mouse behavior and disease models advances, there will be a necessity to perform astrocyte-specific, temporally controlled, and pan-astrocytic genetic manipulations, as well as study aspects of their signaling in physiologically relevant compartments such as processes. The resources we report are valuable in these regards. However, we emphasize that we did not examine tamoxifen-inducible reporter expression in very young mice or in adult mice greater than 3 weeks after tamoxifen administration; we evaluated mice at $P80. Hence, our results need to be interpreted with this in mind and future users of the Aldh1l1-Cre/ERT2 mice will need to perform their own controls: it is important not to extrapolate to all brain areas, all ages, all experimental settings, and all reporter mice from any one study, including ours. Hence, our studies do not obviate the need for controls, especially in disease-related research where gene expression patterns and cell fates may change significantly. We have specifically focused on adult mice and the expression of GECIs at levels appropriate for imaging in brain slices and in vivo. These analyses reveal Aldh1l1-Cre/ERT2 mice to be valuable tools for studying astrocyte biology.
EXPERIMENTAL PROCEDURES
All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Chancellor's Animal Research Committee at the University of California, Los Angeles. Detailed procedures are provided in the Supplemental Information.
Generation of Aldh1l1-Cre/ERT2, Slc6a11-Cre/ERT2, and LckGCaMP6f flox Mice BAC transgenic mice expressing Cre/ERT2 from the Aldh1l1 and Slc6a11 locus were made using published methods (Yang and Gong, 2005) . The LckGCaMP6f flox mice contain a CAG promoter, followed by a loxP-3xSV40pA-loxP cassette, followed by the Lck-GCaMP6f cDNA at the ROSA26 locus. In brief, ROSA26 targeting plasmid, called Ai39, was purchased from Addgene (plasmid #34884) and then modified to create the ROSA26 Lck-GCaMP6f targeting vector. Knockin mice were then made using well-established methods.
Our mouse lines will be available from 
Data Analyses
Calcium signals were analyzed using MiniAnalysis program 6.0.7 (Synaptosoft) and Origin 8.5 (Origin Lab). Image analyses were performed using ImageJ v1.30 (NIH). In brief, the data were analyzed as previously reported (Srinivasan et al., 2015) . Data for ATP-evoked responses were analyzed from circular 50 mm 2 ROIs, encompassing astrocyte territories, and data for PE-evoked responses were acquired from square 10 mm 2 ROIs drawn within individual astrocyte territories. Time traces of fluorescence intensity were extracted from the ROIs and converted to dF/F values, and the time to peak, response amplitude, and decay time were measured using a data selector function in Origin 2015 (Origin Lab). We analyzed spontaneous events that occurred in the first 250 s before agonist application. Events were identified based on amplitudes that were at least 2-fold above the baseline noise of the dF/F trace. Spontaneous events were manually marked, and event amplitudes, half-width, and event frequency per ROI per min were measured using MiniAnalysis 6.0.07 (Synaptosoft).
To generate hippocampal montages such as those in Figure 1 , images of all hippocampal sub-regions (CA1, CA3, and DG) were obtained from 40 mm thick coronal brain sections using a Fluoview 1000 confocal microscope, equipped with a 203 0.85 NA oil immersion lens (Olympus). Images were acquired at 13 digital zoom, such that immediately adjacent images had $150-200 mm of overlapping cellular features. Individual images obtained in this way were manually stitched on a black canvas in Microsoft PowerPoint and then exported as a single TIFF hippocampal montage. During export of the TIFF image, dark boxes appear at the edges of the final images that are reported. These boxes do not represent areas of imaged fluorescence with zero pixel values, but they are areas for which no data were available; we focused on the entire hippocampus for our analyses. Numbers for GFP-positive astrocytes and neurons were acquired by manually counting cells from hippocampal montages. Total numbers of astrocytes or neurons were obtained by counting the number of cells in the montage with S100b or NeuN staining, respectively.
Statistical tests were run in Origin 9 or GraphPad Instat 3. Data are presented as mean ± SEM. Note that in some of the graphs, the bars representing the SEM are smaller than the symbols used to represent the mean. For each set of data to be compared, we determined within GraphPad Instat whether the data were normally distributed or not. If they were normally distributed, we used parametric tests; otherwise, we used non-parametric tests. Paired and unpaired Student's two-tailed t tests (as appropriate) and two-tailed Mann-Whitney tests were used for most statistical analyses with significance declared at p < 0.05, but stated in each case with a precise p value. When the p value was less than 0.0001, it is stated as p < 0.0001 to save space. The numbers of cells and/or mice are defined throughout on a case-by-case basis depending on the particular experiment.
ACCESSION NUMBERS
Raw and normalized RNA-seq data have been deposited in the Gene Expression Omnibus repository (http://www.ncbi.nlm.nih.gov/geo) under accession number GEO: GSE84540. Figures 1, 2, 3 , 4, 6A, and S1-S6; Movie S1; and Table 1 were gathered by R.S. Also, two of the three mice were made by R.S. Data in Figures 7C-7G and S7, and Tables  S4A-S4D were gathered by H.C. Data in Figures 5, 6B , 7A, and 7B were gathered by T.-Y.L.
